NCT02017678View on ClinicalTrials.gov

Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

June 30, 2015

Conditions
Ovarian Cancer
Interventions
BIOLOGICAL

JX-594

5 weekly IV infusions of JX-594 followed by laparoscopy and biopsy on day 10 or 38.

Trial Locations (1)

Unknown

Princess Margaret Cancer Center, Toronto

Sponsors
All Listed Sponsors
collaborator

Ontario Institute for Cancer Research

OTHER

lead

Andrea McCart

OTHER